Even as scans get faster and cheaper, many diseases still have unknown or sketchy genetic correlates. How much stock should consumers put in personal genome sequencing?
A new breed of vaccine is being developed that will make possible immunizations tailored to your genetic profile. But how long will it be until your personalized booster shots are ready?
As researchers learn more about genetic profile of various cancers, other work is charging ahead to deliver personalized vaccines targeted to a patient's own tumor cells
For those of you who like stories with simple plots and tidy endings, I must confess the tale of the Human Genome Project isn't one of those. The story didn't reach its conclusion when we unveiled the first draft of the human genetic blueprint at the White House on June 26, 2000.
A noninvasive screening method could provide expectant parents with unprecedented and comprehensive fetal genetic data, but it also presents new ethical quandaries
White House’s move to develop customized care prompts worries about data security and informed consent
The Federal Trade Commission says GeneLink, which served 30,000 customers, made claims not based on science and failed to protect consumer information
The genetic-testing company's real goal is to hoard your personal data
We shield social security numbers, conceal credit cards and shred sensitive records. Now it's time to think about how closely we guard our genomes
Schizophrenia involves some of the same genetic variations as autism and attention deficit disorders, a new whole-genome study has confirmed.
Schizophrenia, which affects about 1.5 percent of the U.S.
Although unique genetic variations in children with autism are nearly as rare as they are in the general population, comprehensive studies are starting to find patterns in disrupted genes and pathways
A host of genome-wide studies has shown that a man's genetic makeup can predispose him to prostate cancer, currently the most common form of cancer in men other than skin cancer.
The diversity of germs in the human gut suggests microbiota play a greater role in health than previously thought, even driving obesity and other metabolic conditions
The long and winding journey to the roots of Alzheimer's disease, the most common form of dementia, has turned up three new genetic clues—the first major ones in 15 years.
A new sense for how variable numbers of genes cause disease
Learn how to put aside unjustified fears and hopes and how to weigh your real risk of illness—or likelihood of recovery
Ten people today allowed their genetic maps to be publicly displayed on the Web in the name of research. The effort is part of Harvard Medical School's Personal Genome Project (PGP), which aims to create a large public database of human DNA to aid researchers in their quest to find the causes and cures for genetic maladies.
The first 10 volunteers, dubbed the PGP-10, include project director and Harvard Medical School geneticist George Church; Harvard psychologist Steven Pinker; technology writer Esther Dyson; Duke University science editor Misha Angrist; Keith Batchelder, CEO of Genomic Healthcare Strategies in Charlestown, Mass.; Rosalynn Gill, founder of personalized health company Sciona in Aurora, Colo.; John Halamka, technology dean at Harvard Medical School; Stanley Lapidus, chairman and CEO of Helicos BioSciences Corp.
In spite of recent legislation, tougher laws are needed to prevent insurers and employers from discriminating on the basis of genetic tests
Law would bar insurers and employers from discriminating based on genetic testing
A study of over 38,000 hypertension patients (the ALLHAT study, for Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial) finds that individuals respond better to some drugs than to others, based on their personal genetics. Steve Mirsky reports.
Doubts about whether commercial DNA scans improve health
Researchers hope the effort will speed up the discovery of many diseases's genetic roots
Next-generation technologies that make reading DNA fast, cheap and widely accessible are coming in less than a decade. Their potential to revolutionize research and bring about the era of truly personalized medicine means the time to start preparing is now
The U.K. plans a national genomic database to study late-onset sickness
As comprehensive genetic tests become more widespread, patients and experts mull how to deal with unexpected findings
Finding individual differences in tumors is key to treating the right patient with the right medicine at the right time, researchers say
Will medicine finally get personal?
The use of predictive genetic tests is still limited to a handful of relatively rare and highly hereditary diseases, but that's about to change